Ontology highlight
ABSTRACT:
SUBMITTER: McCurdy SR
PROVIDER: S-EPMC4424420 | biostudies-other | 2015 May
REPOSITORIES: biostudies-other
McCurdy Shannon R SR Kanakry Jennifer A JA Showel Margaret M MM Tsai Hua-Ling HL Bolaños-Meade Javier J Rosner Gary L GL Kanakry Christopher G CG Perica Karlo K Symons Heather J HJ Brodsky Robert A RA Gladstone Douglas E DE Huff Carol Ann CA Pratz Keith W KW Prince Gabrielle T GT Dezern Amy E AE Gojo Ivana I Matsui William H WH Borrello Ivan I McDevitt Michael A MA Swinnen Lode J LJ Smith B Douglas BD Levis Mark J MJ Ambinder Richard F RF Luznik Leo L Jones Richard J RJ Fuchs Ephraim J EJ Kasamon Yvette L YL
Blood 20150326 19
Related HLA-haploidentical blood or marrow transplantation (BMT) with high-dose posttransplantation cyclophosphamide (PTCy) is being increasingly used because of its acceptable safety profile. To better define outcomes of nonmyeloablative (NMA) HLA-haploidentical BMT with PTCy, 372 consecutive adult hematologic malignancy patients who underwent this procedure were retrospectively studied. Risk-stratified outcomes were evaluated using the refined Disease Risk Index (DRI), developed to stratify di ...[more]